Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors.
Valés-Gómez M, Chisholm SE, Cassady-Cain RL, Roda-Navarro P, Reyburn HT. Valés-Gómez M, et al. Cancer Res. 2008 Mar 1;68(5):1546-54. doi: 10.1158/0008-5472.CAN-07-2973. Cancer Res. 2008. PMID: 18316620 Free article.
Here, we show that cells treated with proteasome inhibitors can become more susceptible to cytotoxicity mediated by natural killer cells because of the induction of expression of ligands for NKG2D, specifically ULBP2, but not down-regulat …
Here, we show that cells treated with proteasome inhibitors can become more susceptible to cytotoxicity mediated by natural ki …
Proteasome regulation of ULBP1 transcription.
Butler JE, Moore MB, Presnell SR, Chan HW, Chalupny NJ, Lutz CT. Butler JE, et al. J Immunol. 2009 May 15;182(10):6600-9. doi: 10.4049/jimmunol.0801214. J Immunol. 2009. PMID: 19414815 Free PMC article.
Killer lymphocytes recognize stress-activated NKG2D ligands on tumors. We examined NKG2D ligand expression in head and neck squamous cell carcinoma (HNSCC) cells and other cell lines. ...The selective induction of ULB …
Killer lymphocytes recognize stress-activated NKG2D ligands on tumors. We examined NKG2D ligand expression
Feedback